Although we do not observe any difference in average response to BCR modulation between MCL and HD samples, interpatient response variability—specifically for pBTK, pPLCγ2, and pSTAT5—is higher within MCL than HD samples, confirming that MCL is a disease with heterogeneous biological features and BCR signaling11,34. Here, BCR is linked to mantle cell lymphoma.